Debora A. Jorn

Overview

Debora A. Jorn received an average of $3M in total compensation, including $442K in salary, at Valeant Pharmaceuticals International from 2013 to 2015.

Source: SEC filing on April 29, 2016.

Related executives

We found 27 more executives who work or worked at Valeant Pharmaceuticals International.

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

Thomas Appio

Valeant Pharmaceuticals International

President Co, Head Bausch + Lomb/International

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

Sam Eldessouky

Valeant Pharmaceuticals International

Chief Financial Officer

Robert Spurr

Valeant Pharmaceuticals International

President, U.S. Pharma Business

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

William Humphries

Valeant Pharmaceuticals International

Group Chairman

You may also like